Peter Salzmann
Chief Executive Officer at IMMUNOVANT, INC.
Net worth: 29 M $ as of 2024-04-29
Peter Salzmann active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 2020-03-05 | - |
| Independent Dir/Board Member | 2020-03-05 | - | |
| IMMUNOVANT, INC. | Director/Board Member | 2019-09-30 | - |
| Chief Executive Officer | 2019-05-31 | - | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Director/Board Member | - | - |
| IMVT Corp. | Chief Executive Officer | - | - |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Director/Board Member | 2019-09-30 | - |
Career history of Peter Salzmann
Former positions of Peter Salzmann
| Companies | Position | Start | End |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2010-12-31 | 2019-05-31 |
| Eli Lilly Asia, Inc. | Sales & Marketing | 2007-12-31 | 2010-11-30 |
Training of Peter Salzmann
| Northwestern University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
| Pritzker School of Medicine | Doctorate Degree |
Statistics
International
| United States | 9 |
| China | 2 |
| Bermuda | 2 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| IMMUNOVANT, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
| Eli Lilly Asia, Inc. | |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Health Technology |
| IMVT Corp. |
- Stock Market
- Insiders
- Peter Salzmann
- Experience
